New combination cholesterol drug, Liptruzet by Merck, has received approval by FDA. This drug helps in lowering a patient's low-density lipoprotein (LDL) cholesterol levels.
This drug is a mix of drugs ezetimibe and atorvastatin and works well in the treatment of hyperlipidemia.
The FDA has approved the use of this drug to treat elevated LDL levels especially in cases where diet and lifestyle changes have not helped in making a difference to "bad cholesterol" levels.
Every 1% reduction in your cholesterol level lowers your risk of heart disease by 2%. Each increase of 1 mg/dL (not percent) of your good cholesterol decreases your risk 2-3%.